Topics

Sobi pays CHF515mm to buy newco housing Gamifant from Novimmune

15:40 EDT 17 Jun 2019 | Elsevier Business Intelligence

One year after granting Swedish Orphan Biovitrum AB (Sobi) exclusive global rights to the interferon gamma antagonist emapalu...

Original Article: Sobi pays CHF515mm to buy newco housing Gamifant from Novimmune

NEXT ARTICLE

More From BioPortfolio on "Sobi pays CHF515mm to buy newco housing Gamifant from Novimmune"

Quick Search